White House Proposal Encourages Companies To Offer Fertility Treatment Benefits

A new proposed rule from the Trump administration aims to make it easier for employers to offer coverage of fertility treatments, as part of larger efforts to expand access to fertility services including in-vitro fertilization.

The new rule released Sunday from the Department of Labor would create a new exempted insurance benefit — in the same category as dental and vision benefit coverage— for treating infertility.

Exempted benefits don’t have to meet certain requirements under the Affordable Care Act and other federal healthcare coverage laws.

The proposal wouldn’t require coverage but would allow companies to offer it if they choose to do so. The rule aims to increase benefit options and make IVF and other fertility treatments more affordable, though the proposed rule does not entirely eliminate costs to the recipient.

“This will hopefully reduce the number of couples who need to resort to IVF, because challenges can be identified and addressed early in the process,” President Trump said during a maternal health event in the Oval Office Monday.

Fertility treatments can cost tens of thousands of dollars, and while most workers of reproductive age receive healthcare coverage through their jobs, the majority do not have robust fertility coverage, the Department of Labor said in a statement.

The employer-sponsored fertility benefits would have a lifetime benefit cap of $120,000 and requirements for the employer to provide a notice that “clearly describes the coverage,” requirements that are similar to other limited excepted benefits.

Under the proposal, the benefits must be for diagnosis, mitigation, or treatment of infertility or related reproductive health conditions.

Mehmet Oz, administrator for the Centers for Medicare and Medicaid Services, said private companies were “taking advantage” of available treatments.

“As services get better, we make them more affordable, we’ll have more Trump babies,” Oz said Monday.

The rule builds on an executive order signed by Trump in February that asked for policy recommendations to reduce the cost of fertility treatments.

“The decline in birth rates is a serious challenge for our nation,” Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement. “Under President Trump’s leadership, this rule expands access to fertility care and gives more Americans a real path to starting and growing their families.”

The American Society of Reproductive Medicine in a statement said it the group was “encouraged” that the Trump administration was continuing to try to make IVF treatments more affordable.

“The latest proposed step, allowing employers to voluntarily provide coverage as an ‘excepted benefit,’ may indeed increase access, but will not yet fulfill that promise,” Sean Tipton, ASRM’s Chief Advocacy and Policy Officer said in a statement.

Tipton noted the proposed rule is merely a draft for public comment, and encouraged “all concerned citizens to review it and make their voices heard.”

 

Source Link 

Recommended Articles

Trump Administration Demands Hospitals Share Emergency Room Records

A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that some of the nation’s biggest health systems turn over detailed, personally identifiable medical records of all patients who seek help at their emergency rooms. The Consumer Product Safety Commission, responsible for tracking and issuing recalls ...

Read More

21 States File Lawsuit Challenging 2027 ACA Payment Rule

A coalition of attorneys general from 21 states, along with Pennsylvania Gov. Josh Shapiro, have filed a lawsuit challenging a federal rule that they allege undermines the Affordable Care Act and makes health insurance more expensive and harder to obtain for millions of Americans. The lawsuit seeks to block provisions of the Trump administration’s ACA ...

Read More

Erica Schwartz, Trump’s CDC Pick Wins Senate Confirmation

The Senate voted to confirm President Donald Trump’s nominee, Erica Schwartz, to run the Centers for Disease Control and Prevention on Wednesday, ending a nearly yearlong period without a Senate-confirmed director leading the agency. Schwartz was confirmed in a 51-44 vote, with Sen. Tim Kaine (D-Va.) joining Republicans in support. All other Democrats opposed the nomination. Despite a ...

Read More

Specialty Drug Costs Expected To Jump 32% By 2028, PSG Finds

Specialty drug trend remains high, although it decreased from 11.2% to 10.8% on a gross cost basis in Pharmacy Strategies Group’s 2026 State of Specialty Spend and Trend Report. Claim utilization is now the dominant driver of specialty drug trend as the percentage of members using specialty drugs rose to 5.5%. “For a decade, this report ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square